Interleukin-17 immunity in pediatric crohn disease and ulcerative colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 3, 2013, Pages 287-292

  Hölttä, Veera ^b   Klemetti, Paula ^b   Salo, Harri M ^a   Koivusalo, Antti ^b   Pakarinen, Mikko ^b   Westerholm Ormio, Mia ^b   Kolho, Kaija Leena ^b   Vaarala, Outi ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

children; FOXP3; IL 22; IL 6; inflammatory bowel disease

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 22; INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CROHN DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; ULCERATIVE COLITIS; UPREGULATION; CD4+ T LYMPHOCYTE; COLON; GENETICS; ILEUM; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MONONUCLEAR CELL;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; ILEUM; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; INTERLEUKINS; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; MALE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84883700684     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182979252     Document Type: Article

References (25)

1. Biank V, Broeckel U, Kugathasan S. Pediatric inflammatory bowel disease: clinical and molecular genetics. Inflamm Bowel Dis 2007; 13: 1430-8. (Pubitemid 350206858)
2. Turunen P, Ashorn M, Auvinen A., et al. Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2009; 15: 56-62.
3. Heyman MB, Kirschner BS, Gold B.D., et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146: 35-40. (Pubitemid 40091728)
4. Henderson P, van Limbergen JE, Wilson DC, et al. Genetics of childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 346-61.
5. Nieuwenhuis EE, Escher JC Early onset IBD: what's the difference? Dig Liver Dis 2008; 40: 12-5. (Pubitemid 350246388)
6. Kugathasan S, Saubermann LJ, Smith L, et al Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut 2007; 56: 1696-705. (Pubitemid 350206296)
7. Damen GM, Hol J, de Ruiter L, et al. Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2006; 42: 142-9.
8. Fujino S, Andoh A, Bamba S., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70. (Pubitemid 36020767)
9. Holtta V, Klemetti P, Sipponen T., et al. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm Bowel Dis 2008; 14: 1175-84.
10. Seiderer J, Elben I, Diegelmann J., et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008; 14: 437-45. (Pubitemid 351571823)
11. Holtta V, Sipponen T, Westerholm-Ormio M, et al. In Crohn's disease, anti-TNF-alpha treatment changes the balance between mucosal IL-17, FOXP3, and CD4 cells. ISRN Gastroenterol 2012; 2012: 505432.
12. Verdier J, Begue B, Cerf-Bensussan N, et al. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18: 1260-6.
13. Wolk K, Kunz S, Witte E., et al. IL-22 increases the innate immunity of tissues. Immunity 2004; 21: 241-54. (Pubitemid 39094053)
14. Brand S, Beigel F, Olszak T., et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38.
15. Andoh A, Zhang Z, Inatomi O., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005; 129: 969-84. (Pubitemid 41242688)
16. Bettelli E, Oukka M, Kuchroo VK T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-50. (Pubitemid 46745409)
17. Maul J, Loddenkemper C, Mundt P., et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005; 128: 1868-78. (Pubitemid 40824698)
18. Reikvam DH, Perminow G, Lyckander L.G., et al. Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients. Scand J Gastroenterol 2011; 46: 550-60.
19. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2-6. discussion 16-9 (Pubitemid 20015811)
20. Klemetti P, Savilahti E, Ilonen J., et al. T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus. Scand J Immunol 1998; 47: 48-53. (Pubitemid 28057351)
21. Chatila T. Molecular mechanisms of regulatory T cell development. J Clin Immunol 2008; 28: 625-30.
22. Zhou L, Lopes JE, Chong M.M., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453: 236-40. (Pubitemid 351667978)
23. Geremia A, Arancibia-Carcamo CV, Fleming M.P., et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208: 1127-33.
24. Makita S, Kanai T, Oshima S., et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004; 173: 3119-30. (Pubitemid 39142018)
25. La Scaleia R., Morrone S, Stoppacciaro A., et al. Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2010; 51: 563-72.